ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Total Assets

Everything the company owns or controls; equal to total liabilities plus equity.

No reported Total Assets figures are available to summarize.

Total Assets history

Currency unavailable · from the balance sheet

No Total Assets data reported for this period type.

Total Assets vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Total Assets for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR
WVEWave Life Sciences Ltd.Mar 2026$583.54M USD+102.4%+63.4%
STOKStoke Therapeutics, Inc.Mar 2026$443.28M USD+8.9%+17.8%
PRMEPrime Medicine, Inc.Mar 2026$294.73M USD-10.2%-1.7%
RNAAtrium Therapeutics, Inc.Mar 2026$292.36M USD——
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$245.41M USD-26.0%-15.6%
MGTXMeiraGTx Holdings plcMar 2026$244.66M USD+9.2%-8.4%
BNTCBenitec Biopharma Inc.Mar 2026$187M USD+77.7%+155.5%
SLNSilence Therapeutics plcMar 2026$115.12M USD-37.9%+6.9%
PRQRProQR Therapeutics N.V.Mar 2026€99.14M EUR-39.5%-13.0%
ADRXADARx Pharmaceuticals, Inc.—— ——
Peer median (excluding ADRX) —-0.6%+2.6%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.